Please use this identifier to cite or link to this item:
https://doi.org/10.1097/JTO.0b013e3181913e28
| Title: | Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) | Authors: | Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. |
Keywords: | Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification |
Issue Date: | 2009 | Citation: | Lim, E.H., Chang, A., Tan, P., Zhang, S.-L., Li, J.-L., Yap, W.-S., Ng, A., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M. (2009). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 4 (1) : 12-21. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181913e28 | Source Title: | Journal of Thoracic Oncology | URI: | http://scholarbank.nus.edu.sg/handle/10635/24184 | ISSN: | 15560864 15561380 |
DOI: | 10.1097/JTO.0b013e3181913e28 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
63
checked on May 31, 2023
WEB OF SCIENCETM
Citations
63
checked on May 31, 2023
Page view(s)
387
checked on May 25, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.